Science 37 Holdings, Inc. (NASDAQ:SNCE) Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET

Company Participants

Caroline Paul - Investor Relations

David Coman - Chief Executive Officer

Mike Zaranek - Chief Financial Officer

Conference Call Participants

Eric Coldwell - Robert W. Baird & Co.

Justin Lin - William Blair

Frank Takkinen - Lake Street Capital Markets

Operator

Good morning, ladies and gentlemen, and welcome to Science 37’s Earnings Conference Call for the Quarter Ended March 31, 2022. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Caroline Paul of Investor Relations for a few introductory comments.

Caroline Paul

Thank you, and thank you all for participating in today's call. Joining me are David Coman, Chief Executive Officer; and Mike Zaranek, Chief Financial Officer. Earlier today, Science 37 released financial results for the quarter ended March 31, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of Federal Securities Laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon our current estimates and various assumptions and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. We encourage you to review our filings made with the Securities and Exchange Commission for a discussion of these risk factors, including our quarterly report on Form 10-Q for the quarter ended March 31, 2022 which was filed earlier today. You are cautioned not to place undue reliance on these forward-looking statements which we speak only as of today, and the company disclaims any obligation to update such statements for new information.

We believe that certain non-GAAP metrics are useful in evaluating our operational performance. We use these non-GAAP measures to evaluate our ongoing operations and for internal planning and forecasting purposes. Information about non-GAAP financial measures referenced, including a reconciliation of those measures to the most comparable GAAP measures can be found in our SEC filings, and the earnings materials available on the Investor Relations portion of our website at investors.science37.com.